InvestorsObserver
×
News Home

Market Reactions to Cocrystal Pharma Inc (COCP) Stock Getting a Bullish Rating

Wednesday, July 08, 2020 11:08 AM | InvestorsObserver Analysts

Mentioned in this article

Market Reactions to Cocrystal Pharma Inc (COCP) Stock Getting a Bullish Rating

The market has been high on Cocrystal Pharma Inc (COCP) stock recently. COCP gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
Cocrystal Pharma Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on COCP!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.

Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.

InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.

Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With COCP Stock Today?

Cocrystal Pharma Inc (COCP) stock is trading at $1.73 as of 11:01 AM on Wednesday, Jul 8, a gain of $0.13, or 7.81% from the previous closing price of $1.60. The stock has traded between $1.68 and $1.84 so far today. Volume today is 5,062,651 compared to average volume of 4,683,116.

To see the top 5 stocks in the Biotechnology industry click here.

More About Cocrystal Pharma Inc

Cocrystal Pharma Inc is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. The company employs structure-based technologies and Nobel Prize-winning expertise to create first-and best-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). CC-31244 is currently being evaluated in a Phase 2a study for the treatment of hepatitis C as part of a cocktail for ultra-short therapy of 4 to 6 weeks.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App